CLINICAL_TRIALS
research
· 2026-02-05
Clinical Trial Update: TBE Zone 2 PMS in Japan
Summary
Clinical trial update indicates Gore's TBE Zone 2 post-market surveillance in Japan, currently recruiting for thoracic aortic conditions including thoracic aort…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: W.L.Gore & Associates | Conditions: Aneurysm Thoracic, Dissection of Aorta, Thoracic | Status: RECRUITING